Self-sampling versus physician-sampling for human papillomavirus testing

International Journal of STD and AIDS

Volumn 16, Issue 11, 2005, Pages 727-729

  Agorastos, Theodoros ^a,e   Dinas, K ^a   Lloveras, B ^b   Font, R ^c   Kornegay, J R ^d   Bontis, J ^a   De Sanjose, S ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d ROCHE MOLECULAR SYSTEMS   (United States)

^e NONE   (Greece)

Author keywords

Human papillomavirus; Screening for cervical dysplasia; Self sampling

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC PROCEDURE; FEMALE; GENDER; GREECE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PHYSICIAN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SAMPLING; SCREENING; STATISTICAL ANALYSIS; UTERINE CERVIX; UTERINE CERVIX DYSPLASIA; VAGINA; VERRUCA VULGARIS; VIRUS DETECTION; WART VIRUS;

CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SELF CARE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; UTERINE CERVICAL DYSPLASIA; VAGINA;

EID: 27844593204     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646205774763225     Document Type: Article

References (19)

1. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
2. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65
3. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000;9:945-51
4. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93
5. Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362:1871-6
6. Wright Jr TC, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:81-6
7. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed - biologic concordance and women's preferences. Am J Obstet Gynecol 2002;186:365-73
8. Garcia F, Barker B, Santos C, et al. Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus. Obstet Gynecol 2003;102:266-72
9. Agorastos T, Dinas K, Lloveras B, et al. Cervical human papillomavirus infection in women attending gynecologic outpatient clinics in Northern Greece. Eur J Cancer Prev 2004;13:145-7
10. Anastasiadis PG, Koutlaki NG, Liberis VA. Trends in epidemiology of cervical cancer in Thrace, Greece. Int J Gynaecol Obstet 2000;68:59-60
11. Riza E, Kyriakogianni-Psaropoulou P, Koumantakis E, Symiakaki H, Garas I, Linos A. Cervical cancer in Greece. Eur J Cancer 2000;36:2227-32
12. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61
13. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reserve line blot detection method. J Clin Microbiol 1998;36:3020-7
14. Franco EL. Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr 2003;127:946-9
15. Franco EL. Are we ready for a paradigm change in cervical cancer screening? Lancet 2003;362:1866-7
16. Salmeron J, Lazcano-Ponce E, Lorincz A, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003;14:505-12
17. Hillemans P, Kimmig R, Huettemann U, Dannecker C, Thaler CJ. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet 1999; 354:1970
18. Dzuba IG, Diaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing vs the pap test as alternatives in cervical cancer screening. J Womens Health Gender Based Med 2002;11:265-75
19. Canadas MP, Bosch XF, Junquera ML, et al. Human papillomavirus concordance for ano-genital and oral infection in a high-risk population. J Clin Microbiol 2004;42:1330-2